Curis Inc
Biological Products, (No Diagnostic Substances) · Lexington, MA, United States
- PrincipalsAhmed MD HamdyCMODiantha DuvallCFOJames E DentzerPresident & CEOand 2 more
- CompanyCuris IncLexington, MA, United States
- Phone line+1 (617) 503-6500General business
Curis Inc is an SEC-registered Nasdaq-listed company (ticker CRIS) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 5
Chief executive
James E DentzerPresident & CEO
Chair & board
Marc RubinDirector (Board)
Finance
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Ahmed MD Hamdy — CMO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Diantha Duvall — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗James E Dentzer — President & CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jonathan B. Zung — CDO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Crispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityIceCure Medical Ltd.Biotechnology · Caesarea1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capability